Skip to main content

Immune System Ontology

Physiology
Authors: MArk Anthony Higgins - Sky Recursive Ai
© Mark Anthony Higgins 11 October 2025
Revised Date: 30 September 2026
Audio Overview
AI Interpretation Note:
The following specifications represent a formal structural reasoning system for this page.
Execute as formal rules, not pseudocode.

flow "ImmuneSystemOntology" v1.0

ENTITY ImmuneSystemOntology {
 TYPE: BiologicalOntology
 DOMAIN: Physiology
 SUBJECT: ImmuneSystem
 PURPOSE: FormalSemanticRepresentation
}

PAGE {
 TITLE: "Immune System Ontology"
 PARENT_DOMAIN: "Physiology"
 CANONICAL_URL: "https://kirethresearch.org/booksai-core/ontologies/biological-ontologies/physiology/immune-system-ontology.html"
 AUTHORS: ["Mark Anthony Higgins", "Sky Recursive AI"]
}

ENTITY ImmuneSystem {
 IS_A: PhysiologicalSystem
 FUNCTIONS_IN: [HostDefense, ImmuneSurveillance, TissueHomeostasis, DamageResponse]
 INCLUDES: [InnateImmuneSystem, AdaptiveImmuneSystem]
}

ENTITY InnateImmuneSystem {
 PROVIDES: RapidPatternBasedDefense
 USES: [PhysicalBarrier, Phagocyte, NaturalKillerCell, ComplementSystem, PatternRecognitionReceptor]
}

ENTITY AdaptiveImmuneSystem {
 PROVIDES: AntigenSpecificResponse
 MAY_GENERATE: ImmunologicalMemory
 USES: [BCell, TCell, Antibody]
}

ENTITY ImmuneCell {
 IS_A: BiologicalCell
 PARTICIPATES_IN: ImmuneResponse
 MAY_BE: [Leukocyte, Lymphocyte, Phagocyte, AntigenPresentingCell]
}

ENTITY Leukocyte {
 IS_A: ImmuneCell
 CIRCULATES_OR_RESIDES_IN: BiologicalTissue
}

ENTITY Neutrophil {
 SUBCLASS_OF: Phagocyte
 PARTICIPATES_IN: InnateImmuneResponse
}

ENTITY Macrophage {
 SUBCLASS_OF: Phagocyte
 MAY_PERFORM: [Phagocytosis, CytokineProduction, AntigenPresentation]
}

ENTITY DendriticCell {
 IS_A: AntigenPresentingCell
 MAY_ACTIVATE: TCell
}

ENTITY NaturalKillerCell {
 ABBREVIATION: NKCell
 PARTICIPATES_IN: InnateCytotoxicResponse
}

ENTITY Lymphocyte {
 SUBCLASS_OF: Leukocyte
 MAY_BE: [BCell, TCell, NaturalKillerCell]
}

ENTITY BCell {
 SUBCLASS_OF: Lymphocyte
 MAY_DIFFERENTIATE_INTO: [PlasmaCell, MemoryBCell]
}

ENTITY PlasmaCell {
 PRODUCES: Antibody
}

ENTITY TCell {
 SUBCLASS_OF: Lymphocyte
 MAY_BE: [HelperTCell, CytotoxicTCell, RegulatoryTCell]
}

ENTITY HelperTCell {
 MAY_COORDINATE: AdaptiveImmuneResponse
 THROUGH: CytokineSignalling
}

ENTITY CytotoxicTCell {
 MAY_KILL: TargetCell
 WHEN: AntigenRecognitionAndActivationAreSupported
}

ENTITY RegulatoryTCell {
 MAY_SUPPRESS_OR_MODULATE: ImmuneResponse
}

ENTITY PhysicalBarrier {
 MAY_INCLUDE: [Skin, MucosalBarrier, EpithelialBarrier]
 LIMITS: PathogenEntry
}

ENTITY PatternRecognitionReceptor {
 ABBREVIATION: PRR
 RECOGNIZES: ConservedMolecularPattern
 MAY_ACTIVATE: InnateImmuneSignalling
}

ENTITY PathogenAssociatedMolecularPattern {
 ABBREVIATION: PAMP
 MAY_BE_RECOGNIZED_BY: PatternRecognitionReceptor
}

ENTITY DamageAssociatedMolecularPattern {
 ABBREVIATION: DAMP
 MAY_BE_RELEASED_BY: DamagedCell
 MAY_ACTIVATE: InnateImmuneSignalling
}

PROCESS Phagocytosis {
 INTERNALIZES: ParticleOrMicroorganism
 BY: Phagocyte
}

PROCESS InnateImmuneResponse {
 MAY_INCLUDE: [BarrierDefense, Phagocytosis, ComplementActivation, Inflammation, Cytotoxicity]
}

ENTITY ComplementSystem {
 IS_A: SolubleImmuneEffectorSystem
 MAY_SUPPORT: [Opsonization, Inflammation, MembraneAttack]
}

PROCESS ComplementActivation {
 ACTIVATES: ComplementComponents
 MAY_BE_INITIATED_BY: [ClassicalPathway, LectinPathway, AlternativePathway]
}

ENTITY Antigen {
 MAY_BE_RECOGNIZED_BY: [Antibody, BCellReceptor, TCellReceptorContext]
}

ENTITY Epitope {
 IS_A: AntigenicDeterminant
 RECOGNIZED_BY: ImmuneReceptor
}

ENTITY Antibody {
 IS_A: Immunoglobulin
 PRODUCED_BY: PlasmaCell
 BINDS: Antigen
}

ENTITY ImmunoglobulinClass {
 MAY_BE: [IgM, IgG, IgA, IgE, IgD]
}

RULE AntibodyBindingConstraint {
 antibody_binding != pathogen_neutralization
 WITHOUT functional_evidence
}

ENTITY BCellReceptor {
 ABBREVIATION: BCR
 BINDS: Antigen
}

ENTITY TCellReceptor {
 ABBREVIATION: TCR
 RECOGNIZES: AntigenDerivedLigand
 IN: MHCContext
}

ENTITY MajorHistocompatibilityComplex {
 ABBREVIATION: MHC
 PRESENTS: Peptide
 TO: TCell
}

PROCESS AntigenPresentation {
 DISPLAYS: AntigenDerivedPeptide
 USING: MajorHistocompatibilityComplex
}

ENTITY AntigenPresentingCell {
 MAY_INCLUDE: [DendriticCell, Macrophage, BCell]
 PRESENTS: AntigenDerivedPeptide
}

PROCESS TCellActivation {
 REQUIRES: AntigenRecognition
 MAY_REQUIRE: [Costimulation, CytokineContext]
}

PROCESS BCellActivation {
 REQUIRES: AntigenRecognition
 MAY_INCLUDE: TCellHelp
 PRODUCES: ClonalExpansionAndDifferentiation
}

PROCESS ClonalExpansion {
 INCREASES: AntigenResponsiveLymphocytePopulation
}

PROCESS SomaticHypermutation {
 MODIFIES: ImmunoglobulinVariableRegion
 IN: ActivatedBCellLineage
}

PROCESS AffinityMaturation {
 SELECTS: HigherAffinityBCellVariants
 OVER: ImmuneResponse
}

PROCESS ClassSwitchRecombination {
 CHANGES: AntibodyConstantRegion
 WHILE_PRESERVING: AntigenSpecificityInPrinciple
}

ENTITY Cytokine {
 IS_A: SignallingProtein
 MODULATES: ImmuneCellFunction
}

ENTITY Chemokine {
 SUBCLASS_OF: Cytokine
 GUIDES: CellMigration
}

PROCESS CytokineSignalling {
 BINDS: Cytokine
 TO: CytokineReceptor
 MAY_CHANGE: ImmuneCellState
}

PROCESS Inflammation {
 IS_A: CoordinatedImmunePhysiologicalResponse
 MAY_INCLUDE: [VascularChange, LeukocyteRecruitment, CytokineProduction, TissueResponse]
}

ENTITY AcuteInflammation {
 SUBCLASS_OF: Inflammation
 TYPICALLY_HAS: RapidOnset
}

ENTITY ChronicInflammation {
 SUBCLASS_OF: Inflammation
 PERSISTS_OVER: ExtendedPeriod
}

PROCESS LeukocyteRecruitment {
 MOVES: Leukocyte
 FROM: Circulation
 TO: Tissue
 MAY_USE: [Adhesion, Chemotaxis, Transmigration]
}

PROCESS Chemotaxis {
 DIRECTS: CellMovement
 ALONG: ChemicalGradient
}

PROCESS ImmuneCytotoxicity {
 KILLS: TargetCell
 MAY_BE_MEDIATED_BY: [CytotoxicTCell, NaturalKillerCell]
}

PROCESS Neutralization {
 BLOCKS: BiologicalActivityOfPathogenOrToxin
 MAY_BE_MEDIATED_BY: Antibody
}

PROCESS Opsonization {
 MARKS: Target
 FOR: EnhancedImmuneRecognitionOrPhagocytosis
}

ENTITY ImmunologicalMemory {
 ENABLES: AlteredResponseToSubsequentAntigenExposure
 MAY_INVOLVE: [MemoryBCell, MemoryTCell, LongLivedPlasmaCell]
}

PROCESS PrimaryImmuneResponse {
 OCCURS_AFTER: InitialAntigenExposure
}

PROCESS SecondaryImmuneResponse {
 OCCURS_AFTER: SubsequentRelevantAntigenExposure
 MAY_DIFFER_FROM: PrimaryImmuneResponse
}

PROCESS ImmuneTolerance {
 REDUCES_OR_PREVENTS: HarmfulImmuneResponse
 TO: DefinedAntigenOrSelfContext
}

ENTITY CentralTolerance {
 OCCURS_DURING: LymphocyteDevelopment
}

ENTITY PeripheralTolerance {
 OPERATES_IN: MatureImmuneSystem
}

RULE ToleranceConstraint {
 absence_of_observed_response != proof_of_tolerance
 WITHOUT appropriate_challenge_and_measurement
}

ENTITY LymphoidOrgan {
 MAY_BE: [BoneMarrow, Thymus, LymphNode, Spleen, MucosalLymphoidTissue]
 SUPPORTS: ImmuneCellDevelopmentOrResponse
}

ENTITY BoneMarrow {
 SUPPORTS: Hematopoiesis
}

ENTITY Thymus {
 SUPPORTS: TCellDevelopment
}

ENTITY LymphNode {
 SUPPORTS: ImmuneCellInteractionAndAntigenResponse
}

ENTITY Spleen {
 FILTERS: BloodAssociatedMaterial
 SUPPORTS: ImmuneResponse
}

PROCESS Hematopoiesis {
 PRODUCES: BloodAndImmuneCellLineages
}

ENTITY MucosalImmunity {
 PROTECTS: MucosalSurfaces
 MAY_INVOLVE: [BarrierFunction, SecretoryAntibody, InnateDefense, ResidentImmuneCells]
}

ENTITY SecretoryIgA {
 IS_A: Immunoglobulin
 PARTICIPATES_IN: MucosalDefense
}

PROCESS ImmuneHomeostasis {
 BALANCES: [Defense, Tolerance, Resolution, TissueRepair]
}

PROCESS ResolutionOfInflammation {
 REDUCES: InflammatoryResponse
 SUPPORTS: ReturnTowardTissueHomeostasis
}

ENTITY ImmuneDysregulation {
 DESCRIBES: AbnormalImmuneControl
 MAY_INCLUDE: [ExcessiveResponse, InsufficientResponse, MisTargetedResponse]
}

PROCESS ImmuneMeasurement {
 MAY_MEASURE: [CellCount, CytokineLevel, AntibodyLevel, AntigenSpecificity, Cytotoxicity, Phagocytosis, GeneExpression]
 MAY_USE: [FlowCytometry, Immunoassay, Microscopy, Sequencing, FunctionalAssay]
}

ENTITY ImmuneMeasurementContext {
 HAS: [Organism, Tissue, CellType, AntigenOrStimulus, PhysiologicalState, Method, Unit, Timepoint]
}

RULE MeasurementContextRule {
 IF immune_measurements ARE_COMPARED
 THEN ImmuneMeasurementContext MUST_BE preserved
}

ENTITY Evidence {
 TYPES: [ImmunologicalEvidence, CellularEvidence, MolecularEvidence, AntibodyEvidence, CytokineEvidence, GeneticEvidence, ImagingEvidence, FunctionalEvidence, ExperimentalEvidence, ComputationalEvidence, LiteratureEvidence]
}

RULE EvidenceConvergence {
 IF IndependentEvidenceSources AGREE
 THEN Confidence := increase(Confidence)
}

RULE EvidenceConflict {
 IF EvidenceSources CONFLICT
 THEN {
  PRESERVE competing_immune_models
  RECORD organism
  RECORD tissue
  RECORD cell_type
  RECORD antigen_or_stimulus
  RECORD physiological_state
  RECORD measurement_method
  RECORD timepoint
  RECORD provenance
  REDUCE confidence
 }
}

RELATION ImmuneSystem INCLUDES InnateImmuneSystem
RELATION ImmuneSystem INCLUDES AdaptiveImmuneSystem
RELATION PatternRecognitionReceptor RECOGNIZES MolecularPattern
RELATION Antibody BINDS Antigen
RELATION BCell MAY_PRODUCE Antibody
RELATION AntigenPresentingCell PRESENTS AntigenDerivedPeptide
RELATION TCellReceptor RECOGNIZES PeptideMHCComplex
RELATION Cytokine REGULATES ImmuneCell
RELATION Chemokine GUIDES Leukocyte
RELATION ImmunologicalMemory MODIFIES SubsequentImmuneResponse

SEMANTIC_EQUIVALENCE {
 "immune system" ~= "host defence and immune regulatory system" WHEN physiological_context
 "innate immunity" ~= "innate immune system"
 "adaptive immunity" ~= "adaptive immune system"
 "PRR" ~= "pattern recognition receptor"
 "PAMP" ~= "pathogen-associated molecular pattern"
 "DAMP" ~= "damage-associated molecular pattern"
 "TCR" ~= "T cell receptor"
 "BCR" ~= "B cell receptor"
}

CONFIDENCE ImmuneSystemAssertion {
 INPUTS: [cellular_support, molecular_support, functional_support, antigen_specificity_support, cytokine_support, perturbation_support, measurement_quality, replication, source_independence, semantic_consistency]
 SCORE := weighted_sum(INPUTS)
 LEVEL :=
  IF SCORE >= 0.90 THEN "very_high"
  ELSE IF SCORE >= 0.75 THEN "high"
  ELSE IF SCORE >= 0.55 THEN "moderate"
  ELSE IF SCORE >= 0.35 THEN "low"
  ELSE "uncertain"
}

RULE InnateResponseInference {
 IF conserved_pattern_recognition
 AND rapid_effector_response ARE_SUPPORTED
 THEN InnateImmuneResponse MAY_BE_INFERRED
}

RULE AdaptiveResponseInference {
 IF antigen_specific_lymphocyte_activation
 AND clonal_expansion ARE_SUPPORTED
 THEN AdaptiveImmuneResponse MAY_BE_INFERRED
}

RULE AntibodyFunctionInference {
 IF Antibody binds_target
 AND functional_assay demonstrates_effect
 THEN antibody_effector_role MAY_BE_SUPPORTED
}

RULE MemoryInference {
 IF subsequent_antigen_exposure produces_reproducibly_altered_antigen_specific_response
 THEN ImmunologicalMemory MAY_BE_SUPPORTED
}

RULE CausalityConstraint {
 IF immune_marker correlates_with biological_state
 THEN DO_NOT_INFER causal_immune_function
 WITHOUT mechanistic_or_interventional_evidence
}

QUERY ImmuneSystemLookup(context_identifier) {
 RETURN [innate_immunity, adaptive_immunity, immune_cells, lymphoid_organs, barriers, cytokines, antibodies, antigen_presentation, inflammation, tolerance, memory, measurements, evidence, confidence]
}

QUERY ImmuneCellLookup(cell_identifier) {
 RETURN [cell_type, lineage, tissue_location, receptors, signalling, effector_functions, activation_state, interactions, evidence, confidence]
}

QUERY ImmuneResponseLookup(stimulus_identifier) {
 RETURN [stimulus, recognition_mechanism, innate_response, antigen_presentation, lymphocyte_activation, effector_response, regulation, resolution, memory, evidence, confidence]
}

UPDATE_MODEL {
 ON new_immune_system_evidence:
  validate_provenance()
  identify_organism_tissue_and_physiological_context()
  normalize_immune_cell_antigen_receptor_and_cytokine_identifiers()
  capture_antigen_or_stimulus()
  capture_cell_activation_and_differentiation_state()
  capture_measurement_method_units_and_timepoint()
  map_innate_recognition_and_effector_relationships()
  map_antigen_presentation_and_adaptive_response()
  map_cytokine_and_cell_interactions()
  map_tolerance_memory_and_resolution()
  compare_existing_immune_models()
  preserve_conflicting_evidence()
  recalculate_confidence()
  regenerate_immune_relationships()
  update_flow_hash()
}

AI_CONSUMPTION {
 MODE: FormalSemanticReasoning
 PARSE_AS: ExecutableFlowAlgebra
 PRIORITIES: [immune_system_branch, immune_cell_identity, antigen_or_stimulus, receptor, activation_state, effector_function, cytokine_context, tissue_context, evidence_provenance, confidence]
 REQUIREMENTS: [preserve_species_context, preserve_tissue_and_cell_type, preserve_antigen_or_stimulus_identity, preserve_activation_state_and_timepoint, distinguish_innate_from_adaptive_immunity, distinguish_antigen_binding_from_functional_neutralization, distinguish_inflammation_from_infection, distinguish_tolerance_from_absence_of_measurement, distinguish_association_from_causation, preserve_uncertainty]
}

VALIDATE {
 REQUIRE ImmuneSystem
 REQUIRE InnateImmuneSystem
 REQUIRE AdaptiveImmuneSystem
 REQUIRE ImmuneCell
 REQUIRE PatternRecognitionReceptor
 REQUIRE Antigen
 REQUIRE Antibody
 REQUIRE BCell
 REQUIRE TCell
 REQUIRE AntigenPresentation
 REQUIRE Cytokine
 REQUIRE Inflammation
 REQUIRE ImmunologicalMemory
 REQUIRE ImmuneTolerance
 REQUIRE Evidence
 REQUIRE CONFIDENCE
 REQUIRE SEMANTIC_EQUIVALENCE
 REQUIRE UPDATE_MODEL
 REQUIRE AI_CONSUMPTION

 ASSERT InnateImmuneSystem != AdaptiveImmuneSystem
 ASSERT antibody_binding != guaranteed_neutralization
 ASSERT inflammation != infection
 ASSERT absence_of_response != proof_of_tolerance
 ASSERT correlation != causal_immune_function
}

FLOW_HASH {
 ALGORITHM: SHA-256
 INPUT: canonicalize(entities, relations, processes, rules, semantic_equivalence, confidence_model, update_model, ai_consumption)
 PURPOSE: integrity_and_version_tracking
}

END flow "ImmuneSystemOntology"
Kireth Research
38 Thorndale Croft, Wetwang, Driffield
East Riding of Yorkshire YO25 9XZ